N. Nishimura et al., EFFECTS OF THE DOPAMINE-RELATED DRUG BROMOCRIPTINE ON EVENT-RELATED POTENTIALS AND ITS RELATION TO THE LAW OF INITIAL-VALUE, PSYCHIATRY AND CLINICAL NEUROSCIENCES, 49(1), 1995, pp. 79-86
Effects of the dopamine-related drug bromocriptine (BCT) on event-rela
ted potentials (ERP) were investigated in 18 healthy volunteers. Bromo
criptine 2.5 mg or an inactive placebo was administered according to a
completely randomized double-blind, cross-over design. The ERP were r
ecorded 3 h after medication was given. Although BCT prolonged the P30
0 latency, it had no effect on the amplitudes of the ERP components as
a whole. Bromocriptine increased the latencies of N100, P200 and P300
in the respective short-latency subject group, and decreased the late
ncy of N200 in the long-latency subject group. It increased the amplit
ude of N200 in the low-amplitude subject group. It was concluded that
the prolongation of P300 latency as a whole and the different response
s that take place are dependent on the initial values and were recogni
zed in the effect of a single administration of BCT 2.5 mg. The result
s of this study are discussed in relation to the law of initial value.